Emily Wo, PharmD

Robert Wood Johnson Medical School

New Brunswick, NJ

Disclosures:

Employment: none
Compensation: :Role Topic Description-End Date:
Ownership: none
Leadership: none

Presentations

Sep 29

277 - Alteration Subtype is Prognostic of Intracranial Outcome and Predicts the Benefit of Upfront SRS in EGFR-Mutant NSCLC Brain Metastasis

Room 156

01:10pm - 01:20pm ET